Clear Lax Powder, For Solution
Product Images NDC 41250-306

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Clear Lax (NDC 41250-306). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meijer Distribution Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image 01

Image 01
This is a drug description for a laxative. The name of the product is clearlax, and it is a powder for solution that contains Polyethylene Glycol 3350. The powder is grit-free, unflavored, and helps relieve occasional constipation or irregularity. The package contains 7 once-daily doses, with a net weight of 4.10 oz (118g). The drug facts warn against using the product for more than a week or if you are experiencing rectal bleeding, nausea, bloating, or have abdominal pain. If a sudden change in bowel habits occurs, it is recommended to ask a doctor or pharmacist before use and get medical help if needed. The drug is not recommended for children under 7 and should be kept out of the reach of children. The box provides directions for dosage, and users are advised not to exceed the directed amount without physician advice. If you are experiencing abdominal pain or missing the 17g measuring cap, it's recommended to ask a doctor before using the product. The product is not manufactured or distributed by Bayer Healthcare, the owner of the registered trademark Miralax.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.